(MENAFNEditorial) By 2022, 39% of total proton therapy centers will operate on a single-treatment room model, Says RNCOS.
According to a new research report by RNCOS entitled, US Proton Therapy Market Forecast to 2022, supporting the trend of miniaturized treatment centers, the coming years will witness a rising demand and supply of smaller proton accelerators, which are affordable, easy to use and flexible. This will help various centers to offer proton therapy, in turn, diversifying their service portfolio.
Choosing Compact centers has key advantages such as, makes high-quality proton therapy more widely accessible, reduces the cost and space requirements for adding a proton therapy component to cancer care, and requires significantly less space than a multi-room center.
Currently, US have seven, one treatment room proton therapy centre operational, but by 2022, the number is expected to increase to twelve, one treatment room proton therapy centers. The service providers are increasingly opting for smaller and more compact proton therapy centers, thereby saving on the huge investments required for constructing a proton therapy center. Along with Mevion Medical Systems, Varian, IBA and Hitachi, various other vendors have also announced plans to concentrate on developing smaller proton accelerators.
Research Analysis and Highlights
The report provides an in-depth research and rational analysis of the current status and future prospect of the US Proton Therapy Industry. The report provides detailed analysis of players and service providers present in the country. The proton therapy center analysis provides an estimate of the shortage and demand of centers. Also, an analysis of the equipment providers provides a thorough insight about the proton therapy market in US. The research further covers detailed analysis of potential cancer patients by each state (2015 & 2022), Growth Drivers and Challenges as well as the industry trends.
The report also covers detailed information about active market players in the US proton therapy industry, to enable the clients to understand the market structure and its growth during the forecasted period. In brief, the report, US Proton Therapy Market Outlook 2022 covers all the necessary aspects of the US Proton Therapy industry, providing an in-depth research and prudent analysis of the key segments.
Some of the key highlights of the report include the following:
Growth Drivers such as increasing government support, benefits over conventional radiation therapies and increasing incidence of cancer
Analysis of existing and forthcoming proton therapy centers
Detailed analysis of potential cancer patients by state in 2014 & 2020
Analysis of existing and forthcoming players, service and equipment providers
Leading Players and their share in US Proton Therapy market
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM861.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
ABOUT RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.